Can-Fite BioPharma Ltd.
Patents, Design & Utilities

Last updated:

List of all Can-Fite BioPharma Ltd. patents 5 in total

Status Patent
Grant
Utility: Method for treating fibrotic liver tissue using Cl-IB-MECA External link
Filling date: 6 Sep 2025 Issue date: 5 Apr 2022
Application
Utility: AN A3 ADENOSINE RECEPTOR LIGAND FOR USE FOR ACHIEVING A FAT LOSS EFFECT External link
Filling date: 6 Sep 2025 Issue date: 17 Mar 2022
Application
Utility: A3 ADENOSINE RECEPTOR LIGAND FOR MANAGING CYTOKINE RELEASE SYNDROME External link
Filling date: 6 Sep 2025 Issue date: 11 Mar 2021
Application
Utility: A3 ADENOSINE RECEPTOR LIGAND FOR USE IN TREATING ECTOPIC FAT ACCUMULATION External link
Filling date: 6 Sep 2025 Issue date: 10 Dec 2020
Grant
Utility: Method for treating NASH accompanied by fibrosis using Cl-IB-MECA External link
Filling date: 6 Sep 2025 Issue date: 22 Sep 2020

Showing 1 to 5 of 5 patents.